Thomas Kraft

5PUBLICATIONS
35CO-AUTHORS
Haematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 17, 2026
Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

|Oct 30, 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Jan Eckmann, Tanja Fauti, Marlene Biehl

|Nov 17, 2022
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice.

Jerome Egli, Stefan Heiler, Felix Weber

|Nov 27, 2019
Heparin chromatography as an in vitro predictor for antibody clearance rate through pinocytosis.

Thomas E Kraft, Wolfgang F Richter, Thomas Emrich

|Oct 14, 2016
A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.

Thomas E Kraft, Monique R Heitmeier, Marina Putanko

Pageof 1

Frequent Collaborators

2 joint publications

Bruno Paiva

2 joint publications

Laura Blanco

1 joint publications

Thomas Emrich

1 joint publications

Michaela Schuster